IMS Launches COVID-19 Research Insights Series and Releases Findings from In-Depth Jury Research
Sep 10, 2020
iCrowdMarketing powered by iCrowdNewswire
IMS Launches COVID-19 Research Insights Series and Releases Findings from In-Depth Jury Research
Pensacola, Fla. | IMS ExpertServices has announced the launch the IMS COVID-19 Research Insights Series, including a robust set of findings, analysis, and expert perspective designed to equip the firm’s clients with a clear view of threats, opportunities, and strategies relevant to their practices amid the pandemic.
The thought leadership in the series has been developed through in-depth research efforts spanning several months, including twelve focus groups with potential jurors across three major venues and seven litigation types, nearly 500 community attitude surveys with responses from potential jurors across four representative venues, in-depth discussions with thought leaders and expert witnesses on industry- and practice group-specific implications, and analysis by the firm’s top trial strategy advisors and jury consultants.
The findings released in this series point to a range of shifting juror attitudes and other considerations critical for litigators, including the influence of the pandemic on how potential jurors are evaluating information and making decisions, likely juror views in the context of the pandemic based on factors including venue and type of litigation, and implications of COVID-19 for matters related to commercial insurance and other industries.
“As we monitored the shifting effects of COVID-19 across the courts and our industry, we recognized the acute need to help our clients navigate significant and important shifts catalyzed by the pandemic,” remarked IMS Chief Revenue Officer, James Crane.
IMS has published the series to provide clarity specifically for the firm’s clients around emerging implications from the virus for litigation either directly related to or in the context of COVID-19, and critically, to help them rethink their courtroom strategies in this changing environment.
“Clarity and context are extremely important during this time,” continued Mr. Crane. “Our trial strategy advisors, jury consultants, and the broader research teams who advanced the research underpinning this series unearthed some important complexities, including on how potential jurors are relying on core values to inform their decisions across various types of litigation in the context of COVID-19. We are confident our findings and recommendations discussed in this series will prove valuable for our clients and the broader litigation community, and are honored to be able to deliver these insights during a challenging and transformational moment for our industry.”
“It’s a given that juror attitudes have changed over the past few months,” observed IMS Senior Expert Trial Consultant, Jeremy Young, who coordinated research efforts underpinning the series and has collaborated with trial teams on more than 300 matters over the last eighteen years. Mr. Young underscored the importance of translating the findings around juror attitude shifts into practical applications. “Our focus is explaining not only how they have changed but also, and more importantly, what trial lawyers can to do to adjust their trial strategies.”
The series addresses a variety of topics, themes, and litigation types, and delivers specific insights, practice tips, and recommendations as well as thorough considerations for litigators from expert witnesses and industry authorities. The reports, practice tips, recommendations, videos, and resulting analyses developed through the series focus on actionable guidance to inform how trial lawyers persuade in the current fast-changing environment.
Several sets of key findings and releases from the COVID-19 Research Insights Series, including highlights from twelve focus groups conducted this summer and practice-area specific interviews with expert witnesses, have been made available to the public through the firm’s COVID-19 client resource hub. A curated selection of in-depth, client-exclusive material is also available to the firm’s clients upon registration in the hub and by request. Additional materials and analyses will be added to the series over the next several weeks.
About IMS ExpertServices
IMS ExpertServices delivers consultative trial and expert services for the most influential global firms. Over nearly three decades and through more than 20,000 cases and well over 1,000 trials, clients have trusted IMS to equip them with the perspective and tools they need to help their clients succeed. With offices in the San Francisco Bay Area, Dallas, Pensacola, and New York, the company provides trial strategy consulting, jury consulting, trial graphics consulting, trial presentation consulting, and expert witness recruitment and management. IMS has earned nine consecutive rankings on the Inc. 5000 list, won recognition by The National Law Journal in six categories of its “Best of 2020” awards, by Corporate Counsel Magazine as winner in eight categories of its “Best of 2019” awards, and as “Go-To Thought Leader” for two consecutive years by The National Law Review.
More about IMS ExpertServices can be found at www.expertservices.com.
URL : https://www.ims-expertservices.com/news/ims-launches-covid-19-research-insights-series-and-releases-
Contact Information:
Teresa BarberDirector of Industry Relations
media@expertservices.com
877-934-4880
Tags: English, COVID, COVID-19, litigation, expert, expert witness, business interruption, force majeure, jury, commercial litigation, Big Law, AmLaw 100, business litigation, commercial litigation, pandemic, epidemiologist, business insurance, epidemiology expert, FDA expert, antitrust litigation, securities litigation, securities expert, pandemic expert, health expert, safety expert, environmental expert, damages expert, economic damages, business interruption, business interruption claim, business insurance, reinsurance, insurance claim, insurance dispute, SEC, fraud investigation, white collar investigation, artificial intelligence expert, directors and officers, D&O, D&O insurance, pharmaceutical expert, pharmaceutical trial, liability, statistician, biostatistician, machine learning expert, cybersecurity expert, privacy expert, data privacy expert, act of god, jury consultant, banking expert, corporate investigations expert, litigation research, virtual trial, remote trial, remote hearing, remote jury trial, insurance defense, virus expert, safety regulation expert, insurance coverage expert, insurance brokerage expert, food safety expert, retail safety expert, packing safety expert, health expert, virus transmissions expert, PPE expert, personal protective equipment expert, pharmaceutical expert, pharmaceutical trial, liability, statistician, biostatistician, machine learning expert, cybersecurity expert, privacy expert, data privacy expert, jury consultant, banking expert, act of god, trial presentation, hot seat, hot seat consultant, voir dire, remote voir dire, virtual voir dire, jury research, mock jury, mock trial, trial graphics, expert demonstratives, trial animation, virtual trial presentation, expert witness deposition, expert deposition, expert disclosure, pharmaceutical trials expert, FDA regulations expert, PPP expert, industry standards expert, packaging expert, courtroom demonstratives, social science expert, university system expert, reinsurance expert, engin